Eli Lilly (LLY) Stock Price Prediction: Dear Investors, today we are going to discuss Eli Lilly’s (NYSE: LLY) stock price prediction. If we talk about the graph, we have seen this stock rise for many years.
Talking about the start of 2020, it’s been seen that Eli Lilly’s (NYSE: LLY) is on a huge rise. And its been increasing by 542.32% and now its trading at $849.22
Eli Lilly Company Overview:
The company Eli Lilly’s (NYSE: LLY) was founded in 1876 and went public in 1952. Talking about the past 4 years, Eli Lilly’s market value has grown rapidly from $100 billion to $740 billion. As investors, we always focus on long term investments and what Eli Lilly will do in the next 3 to 5 years and beyond.
That’s why our experts analyze stocks first before delivering stock predictions to our investors. Also, we research projected revenue and net income to provide the best future share price prediction for 2025–2030. Ahead of this article, you will get the future price prediction details, the growth rate, and the key factors that are keeping this share high.
Read More: SoFi Technologies Stock Price Target and Forecast 2025 to 2030
Some Factors about Eli Lilly’s Stock Success:
Talking about the past few years, it has grown like a skyrocket. Let’s talk about revenue and net income.
| Year | Share Price | Revenue | Net Income |
| 2016 | $80.36 | $21.22B | $2.74B |
| 2017 | $77.55 | $19.94B | $0.21B |
| 2018 | $122.13 | $21.49B | $3.23B |
| 2019 | $140.83 | $22.32B | $8.32B |
| 2020 | $206.46 | $24.54B | $6.19B |
| 2021 | $238.31 | $28.32B | $5.58B |
| 2022 | $329.07 | $28.54B | $6.25B |
| 2023 | $745.91 | $34.12B | $5.24B |
Since 2016, Eli Lilly’s revenue has seen a growth of 60%. But its income has seen an increase of 91%. It is a bit difficult to expect a stock price increase of 828% from a stock with 7% annual revenue. Still, investors’ enthusiasm about Eli Lilly’s future drug has had a positive impact on the stock price and development in the price has been seen.
If we talk about 2016, then Eli Lilly stock has seen a jump of 13 times its earnings in the last 12 months. Seeing this, this question comes in the minds of people that is it worth investing in this stock.
Read More: NIO Stock Price Prediction 2024 to 2030
3 Key Factors Driving Eli Lilly’s Stock:
There are 3 key factors involve driving its stock price.
- Innovation in Drug Pipeline: Eli Lilly’s future depends largely on its drug pipeline, which is the main factor in increasing its stock. Some of these include drugs such as cardiometabolic and Verzenio, which can be the reason for its great success.
- Operational Efficiency: This is a strong position to be in, but it also improves cost control and operational efficiency. This gives them a greater chance of increasing net income and revenue growth, which helps the company to be successful over a long period of time.
- Strategic Acquisitions: Since 2020, Eli Lilly has acquired 13 mid-sized companies with strong drug pipelines, which strengthen its research and help in development. Which helps the company in future growth.
Eli Lilly (LLY) Stock Price Prediction 2025-2030
Here you can see the Eli Lilly’s stock’s strong performance, with analysts predicting continued growth. Here’s a simplified forecast for the coming years:
| Year | Estimated Stock Price | % Change From Current Price |
|---|---|---|
| 2025 | $1,140.00 | +34.24% |
| 2026 | $1,250.00 | +47.19% |
| 2027 | $1,520.00 | +78.99% |
| 2028 | $1,300.00 | +53.08% |
| 2029 | $1,623.00 | +91.12% |
| 2030 | $1,850.00 | +117.85% |
These are the estimated price predictions as per the growth of the company till now which are driven by Eli Lilly’s strong drug pipeline and strategic acquisitions.
Read More: Lucid Stock Price Target After Earnings: Analysts Overview